NCT06607250View on ClinicalTrials.gov

Bp-MRI Based Multi-planar VI-RADS

CompletedOBSERVATIONAL
Enrollment

95

Participants

Timeline

Start Date

February 20, 2023

Primary Completion Date

January 30, 2024

Study Completion Date

February 1, 2024

Conditions
Bladder (Urothelial, Transitional Cell) CancerMRI
Interventions
RADIATION

MRI

All enrolled patients underwent multiparametric magnetic resonance imaging, encompassing T2-weighted imaging (T2WI) and magnetic resonance diffusion-weighted imaging (DWI), in the coronal, sagittal, and axial planes.

Trial Locations (1)

210009

The First Affiliated Hospital with Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER